Research and Markets: Vital Signs - The Analyst's Healthcare Perspective - November Issue

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/2rwb9n/vital_signs_the) has announced the addition of the "Vital Signs - The Analyst's Perspective - November Issue" report to their offering.

This issue of Vital Signs, released on December 5, 2014, discusses LabCorp's acquisition of Covance, MedImmune's acquisition of Definiens, the Google X cancer and heart attack detector, and VWR's acquisition of two fluid handling components companies.

This research includes:

  • LabCorp to Acquire Covance for Approximately $5.6 Billion, Creating World's Leading Healthcare Diagnostics Company
  • AstraZeneca's MedImmune to Acquire Definiens for $150 Million
  • Google X: One Small Step for Preventative Medicine, but One Giant Leap for Healthcare
  • VWR Acquires 2 Fluid Handling Components Companies-Integra Companies, Inc. and STI Components, Inc.

For more information visit http://www.researchandmarkets.com/research/2rwb9n/vital_signs_the

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices